Site-Directed Mutagenesis of Cytochrome P450 2D6 and 2C19 Enzymes: Expression and Spectral Characterization of Naturally Occurring Allelic Variants

被引:0
作者
Amelia Nathania Dong
Yan Pan
Uma Devi Palanisamy
Beow Chin Yiap
Nafees Ahemad
Chin Eng Ong
机构
[1] Monash University Malaysia,School of Pharmacy
[2] University of Nottingham Malaysia Campus,Department of Biomedical Science
[3] International Medical University,School of Pharmacy
来源
Applied Biochemistry and Biotechnology | 2018年 / 186卷
关键词
Cytochrome P450; Genetic polymorphism; Protein expression; Site-directed mutagenesis; Spectral assays;
D O I
暂无
中图分类号
学科分类号
摘要
Genetic polymorphism of the cytochrome P450 (CYP) genes particularly affects CYP2D6 and CYP2C19 to a functionally relevant extent, and it is therefore crucial to elucidate the enzyme kinetic and molecular basis for altered catalytic activity of these allelic variants. This study explored the expression and function of the reported alleles CYP2D6*2, CYP2D6*10, CYP2D6*17, CYP2C19*23, CYP2C19*24, and CYP2C19*25 with respect to gene polymorphisms. Site-directed mutagenesis (SDM) was carried out to generate these six alleles. After DNA sequencing, the CYP2D6 and CYP2C19 wild types alongside with their alleles were each independently co-expressed with NADPH-CYP oxidoreductase (OxR) in Escherichia coli. The expressed proteins were analyzed using Western blotting, reduced carbon monoxide (CO) difference spectral scanning, and cytochrome c reductase assay. Results from Western blot revealed the presence of all CYP wild-type and allelic proteins in E. coli membrane fractions. The reduced CO difference spectra scanning presented the distinct peak of absorbance at 450 nm, and the cytochrome c reductase assay has confirmed that spectrally active OxR was expressed in each protein preparation. As a conclusion, the results obtained from this study have proven the CYP variants to be immunoreactive and spectrally active and are suitable for use to examine biotransformation and interaction mechanism of the enzymes.
引用
收藏
页码:132 / 144
页数:12
相关论文
共 212 条
[1]  
Chang GW(1999)The physiological and pharmacological roles of cytochrome P450 isoenzymes Anaesthesia 54 42-50
[2]  
Kam PCA(2006)Crystal structure of human cytochrome P450 2D6 Journal of Biological Chemistry 281 7614-7622
[3]  
Rowland P(2001)Genetic polymorphism of CYP2D6 Indian Journal of Pharmacology 33 147-169
[4]  
Blaney FE(2007)Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects Pharmacolology and Therapeutics 116 496-526
[5]  
Smyth MG(1996)Drug bioinformation by the cytochrome P-450 enzyme system Infections in Medicine 13 463-464
[6]  
Jones JJ(2006)Pharmacogenomics and individualized drug therapy Annual Review of Medicine 57 119-137
[7]  
Leydon VR(1996)The P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature Pharmacogenetics 1 1-42
[8]  
Oxbrow AK(2005)Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity Pharmacogenomics Journal 5 6-13
[9]  
Lewis CJ(2009)Structure of cytochrome P450s and personalized drug Current Medicinal Chemistry 16 232-244
[10]  
Tennant MG(2009)Genetic polymorphism, linkage disequilibrium, halotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese Pharmacogenomics Journal 9 380-394